Literature DB >> 9863040

Asymmetric membrane capsules for osmotic drug delivery II. In vitro and in vivo drug release performance.

A G Thombre1, J R Cardinal, A R DeNoto, D C Gibbes.   

Abstract

In a previous paper, we described asymmetric membrane capsules and a phase inversion process for manufacturing them. In this paper, we describe the in vitro and in vivo drug release characteristics from these capsules. The capsule formulations were developed with model drugs to understand the variables that influenced drug release. Studies were also conducted to understand the drug release mechanism and it was shown that osmotic drug delivery was possible with asymmetric membrane capsules.

Mesh:

Substances:

Year:  1999        PMID: 9863040     DOI: 10.1016/s0168-3659(98)00101-1

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  6 in total

1.  Osmotic flow through asymmetric membrane: a means for controlled delivery of drugs with varying solubility.

Authors:  Anil K Philip; Kamla Pathak
Journal:  AAPS PharmSciTech       Date:  2006-07-07       Impact factor: 3.246

2.  A novel gastro-retentive osmotic pump capsule using asymmetric membrane technology: in vitro and in vivo evaluation.

Authors:  Jin Guan; Liying Zhou; Yusheng Pan; Haitao Han; Hongtao Xu; Weisan Pan
Journal:  Pharm Res       Date:  2009-10-27       Impact factor: 4.200

3.  Mechanistic investigation of drug release from asymmetric membrane tablets: effect of media gradients (osmotic pressure and concentration), and potential coating failures on in vitro release.

Authors:  Mary Tanya Am Ende; Lee A Miller
Journal:  Pharm Res       Date:  2006-12-19       Impact factor: 4.200

4.  Redefinition to bilayer osmotic pump tablets as subterranean river system within mini-earth via three-dimensional structure mechanism.

Authors:  Abi Maharjan; Hongyu Sun; Zeying Cao; Ke Li; Jinping Liu; Jun Liu; Tiqiao Xiao; Guanyun Peng; Junqiu Ji; Peter York; Balmukunda Regmi; Xianzhen Yin; Jiwen Zhang; Li Wu
Journal:  Acta Pharm Sin B       Date:  2021-11-13       Impact factor: 14.903

5.  Asymmetric Membrane Capsules for Extended Delivery of the Weakly Basic Drug Carvedilol.

Authors:  Kumar Guarve; Ghanshyam Das Gupta
Journal:  Pharmaceutics       Date:  2010-05-18       Impact factor: 6.321

6.  Asymmetric membrane osmotic capsules for terbutaline sulphate.

Authors:  N G Gobade; Marina Koland; K H Harish
Journal:  Indian J Pharm Sci       Date:  2012-01       Impact factor: 0.975

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.